Sushmita B. Gordhandas

Sushmita B. Gordhandas

Obstetrics and Gynecology | Oncology

8081 Innovation Park Dr
775
Fairfax, VA 22031

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

A Subset of Serous Tubal Intraepithelial Carcinoma (STIC)-Like Lesions and Concurrent High-Grade Endometrial Carcinoma Are Genomically Related Entities.

A Subset of Serous Tubal Intraepithelial Carcinoma (STIC)-Like Lesions and Concurrent High-Grade Endometrial Carcinoma Are Genomically Related Entities.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: May 02, 2025

Peritoneal washings analysis in endometrial cancer: Comparison of somatic mutation detection with panel sequencing and traditional cytology.

Peritoneal washings analysis in endometrial cancer: Comparison of somatic mutation detection with panel sequencing and traditional cytology.

Journal: Gynecologic oncology

Published: March 19, 2025

Barriers to early detection: Insurance denials for breast MRI screening in women with germline BRCA1/2 mutations.

Barriers to early detection: Insurance denials for breast MRI screening in women with germline BRCA1/2 mutations.

Journal: Gynecologic oncology

Published: October 24, 2024

A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary study.

A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: July 01, 2024

Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities.

Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities.

Journal: Gynecologic oncology

Published: April 03, 2024

Molecular profiling of primary endometrioid endometrial cancer and matched lung metastases: CTNNB1 mutation as a potential driver.

Molecular profiling of primary endometrioid endometrial cancer and matched lung metastases: CTNNB1 mutation as a potential driver.

Journal: Gynecologic oncology reports

Published: February 06, 2024

Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York State.

Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York State.

Journal: Gynecologic oncology

Published: November 08, 2023

Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer.

Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer.

Journal: JCO precision oncology

Published: September 22, 2023

Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review.

Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review.

Journal: JAMA surgery

Published: September 06, 2023

Pathogenic germline variants in patients with endometrial cancer of diverse ancestry.

Pathogenic germline variants in patients with endometrial cancer of diverse ancestry.

Journal: Cancer

Published: June 30, 2023

Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer.

Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer.

Journal: Gynecologic oncology

Published: May 15, 2023

Germline drivers of gynecologic carcinosarcomas.

Germline drivers of gynecologic carcinosarcomas.

Journal: Gynecologic oncology

Published: January 27, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026